Gene · 1973
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of m7G methylation modification patterns and pulmonary vascular immune microenvironment in pulmonary arterial hypertension. | Front Immunol | 2022 | 36544768 | PubTator, text mining | PubMed |
| Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II. | Ann Clin Case Rep | 2022 | 36540866 | PubTator, text mining | PubMed |
| Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex. | Front Pharmacol | 2022 | 36532738 | PubTator, text mining | PubMed |
| m7G-related lncRNAs are potential biomarkers for predicting prognosis and immune responses in patients with oral squamous cell carcinoma. | Front Genet | 2022 | 36531245 | PubTator, text mining | PubMed |
| The pleiotropic roles of eIF5A in cellular life and its therapeutic potential in cancer. | Biochem Soc Trans | 2022 | 36511302 | PubTator, text mining | PubMed |
| Construction of m7G subtype classification on heterogeneity of sepsis. | Front Genet | 2022 | 36506322 | PubTator, text mining | PubMed |
| Decidualization of human endometrial stromal cells requires steroid receptor coactivator-3. | Front Reprod Health | 2022 | 36505394 | PubTator, text mining | PubMed |
| Expression of miRNA-Targeted and Not-Targeted Reporter Genes Shows Mutual Influence and Intercellular Specificity. | Int J Mol Sci | 2022 | 36499386 | PubTator, text mining | PubMed |
| EIF4A inhibition targets bioenergetic homeostasis in AML MOLM-14 cells in vitro and in vivo and synergizes with cytarabine and venetoclax. | J Exp Clin Cancer Res | 2022 | 36482393 | PubTator, text mining | PubMed |
| The prognostic index of m7G-related genes in CRC correlates with immune infiltration. | Sci Rep | 2022 | 36482181 | PubTator, text mining | PubMed |
| IFITM proteins assist cellular uptake of diverse linked chemotypes. | Science | 2022 | 36480603 | PubTator, text mining | PubMed |
| N7-methylguanosine methylation-related regulator genes as biological markers in predicting prognosis for melanoma. | Sci Rep | 2022 | 36473947 | PubTator, text mining | PubMed |
| M7G-related LncRNAs: A comprehensive analysis of the prognosis and immunity in glioma. | Front Genet | 2022 | 36468039 | PubTator, text mining | PubMed |
| Proximity-dependent biotinylation technologies for mapping RNA-protein interactions in live cells. | Front Mol Biosci | 2022 | 36452457 | PubTator, text mining | PubMed |
| A Novel m7G-Related Gene Signature Predicts the Prognosis of Colon Cancer. | Cancers (Basel) | 2022 | 36428620 | PubTator, text mining | PubMed |
| Implications of differential transcription start site selection on chronic myeloid leukemia and prostate cancer cell protein expression. | iScience | 2022 | 36425755 | PubTator, text mining | PubMed |
| A KLK6 Activity-Based Probe Reveals a Role for KLK6 Activity in Pancreatic Cancer Cell Invasion. | J Am Chem Soc | 2022 | 36413626 | PubTator, text mining | PubMed |
| Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma. | Front Oncol | 2022 | 36408139 | PubTator, text mining | PubMed |
| m7G regulator-mediated methylation modification patterns define immune cell infiltration and patient survival. | Front Immunol | 2022 | 36389726 | PubTator, text mining | PubMed |
| The Translational Landscape Revealed the Sequential Treatment Containing ATRA plus PI3K/AKT Inhibitors as an Efficient Strategy for AML Therapy. | Pharmaceutics | 2022 | 36365147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1973/papers?page=16